Effect of allogeneic pure platelet-rich plasma, sodium cloxacillin, and their combination for the treatment of subclinical mastitis in crossbred cows

被引:0
|
作者
Lopez, Catalina [1 ]
Duque-Madrid, Paulo Cesar [2 ]
Ceballos-Marquez, Alejandro [2 ]
Carmona, Jorge U. [3 ]
机构
[1] Univ Caldas, Dept Salud Anim, Grp Invest Patol Clin Vet, Manizales, Colombia
[2] Univ Caldas, Dept Prod Agr, Grp Invest Cal Leche & Epidemiol Vet, Manizales, Colombia
[3] Univ Caldas, Dept Salud Anim, Grp Invest Terapia Regenerat, Manizales, Colombia
关键词
platelet-rich plasma; bovine; subclinical mastitis; gram-positive bacteria; growth factors; cytokines; SOMATIC-CELL COUNT; INTRACELLULAR STAPHYLOCOCCUS-AUREUS; BOVINE ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; CYTOKINES TNF-ALPHA; NF-KAPPA-B; ECONOMIC-IMPACT; MILK-YIELD; THERAPY; CURE;
D O I
10.3389/fvets.2024.1432354
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Introduction: Bovine subclinical mastitis (SCM) caused by Gram-positive bacteria is a major cause of economic loss in the dairy industry, exacerbated in situations where antimicrobial resistance is present. Pure platelet-rich plasma (P-PRP) may be a therapeutic alternative for SCM, when used alone or with antibiotics, such as sodium cloxacillin (SC). This study aimed 1) to evaluate the therapeutic efficacy of allogeneic P-PRP, SC, and their combination (P-PRP+SC) in cows with SCM caused by Staphylococcus aureus and by streptococci (Staphylococcus aureus and S. dysgalactiae); 2) to determine the concentrations of somatic cells (SCC), interleukin 1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha) and TGF-beta(1) in milk samples of the cows. Methods: 130 cows from 4 dairy herds completed the study, of which 40 cows were treated with P-PRP (10 mL), 28 cows with SC (5g), 36 with P-PRP+SC (10mL/5g), and 26 did not receive no treatment (negative control group, NCG). Results: The overall bacteriological cure was observed in 10/40 (25%) cows in the P-PRP group, 9/28 (32.14%) animals in the SC group, 26/36 (72.22%) cows in the P-PRP+SC group, and 10/26 (38.46%) animals in the NCG. SCM caused by S. aureus (82/130, 63.08%), was cured in 6/24 (25%) cows treated with P-PRP, 7/24 (29.2%) cows treated with SC, 8/16 (50%) animals treated with P-PRP+SC, and in 8/18 (44.4%) cows in NCG. For SCM caused by the streptococci (48/130, 36.91%), the cure was achieved in 4/12 (33.3%) cows treated with P-PRP, 2/4 (50%) cows treated with SC, 18/20 (90%) cows treated with P-PRP+SC, and in 2/8 (25%) cows of the NCG. SCC was significantly (p < 0.001) affected by the treatment, herd, cure, bacteria group, and number of calvings factors. IL-1 beta milk concentrations were significantly (p < 0.001) influenced by treatment and farm factors, and the interaction between these factors. TNF-alpha milk concentrations were significantly (p < 0.001) influenced by time factor. TGF-beta(1) milk concentrations were significantly affected by the time and cure factors. Conclusion: The combination of P-PRP and SC showed the best therapeutic response (90%) against bovine SCM caused by streptococci. However, none of the treatments showed an effective therapeutic response against S. aureus.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Intramammary treatment using allogeneic pure platelet-rich plasma in cows with subclinical mastitis caused by Gram-positive bacteria
    Paulo C. Duque-Madrid
    Juan Velasco-Bolaños
    Alejandro Ceballos-Márquez
    Catalina López
    Jorge U. Carmona
    Scientific Reports, 11
  • [2] Intramammary treatment using allogeneic pure platelet-rich plasma in cows with subclinical mastitis caused by Gram-positive bacteria
    Duque-Madrid, Paulo C.
    Velasco-Bolanos, Juan
    Ceballos-Marquez, Alejandro
    Lopez, Catalina
    Carmona, Jorge U.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Efficacy of cefquinome and a combination of cloxacillin and ampicillin for treatment of dairy cows with Streptococcus agalactiae subclinical mastitis
    Rossi, Rodolfo Santos
    Amarante, Ariadne Ferreira
    Guerra, Simony Trevisan
    Latosinski, Giulia Soares
    Rossi, Bruna Fernanda
    Mores Rall, Vera Lucia
    de Figueiredo Pantoja, Jose Carlos
    PLOS ONE, 2019, 14 (04):
  • [4] Comparison of Allogeneic Platelet-rich Plasma With Autologous Platelet-rich Plasma for the Treatment of Diabetic Lower Extremity Ulcers
    He, Min
    Guo, Xuewen
    Li, Tao
    Jiang, Xiaoyan
    Chen, Yan
    Yuan, Yi
    Chen, Bing
    Yang, Gangyi
    Fan, Yahan
    Liang, Ziwen
    Armstrong, David G.
    Deng, Wuquan
    CELL TRANSPLANTATION, 2020, 29
  • [5] THE EFFECT OF TREATMENT OF COWS SUBCLINICAL MASTITIS WITH CEFALEXINE AND COMBINATION OF CEFALEXINE WITH AMPICILLIN
    Rudejeviene, Jurate
    Zilaitis, Vytuolis
    Japertiene, Renata
    Miseikiene, Ramute
    VETERINARIJA IR ZOOTECHNIKA, 2011, 55 (77): : 53 - 59
  • [6] Combination of Platelet-Rich Plasma and Hyaluronic Acid vs. Platelet-Rich Plasma Alone for Treatment of Knee Osteoarthritis
    Gupta, Ashim
    Sharma, Surya Prakash
    Potty, Anish G.
    BIOMEDICINES, 2023, 11 (10)
  • [7] Treatment of scalp defects with a combination of trephination and platelet-rich plasma
    Gokkaya, Ali
    Gorgu, Metin
    JOURNAL OF TISSUE VIABILITY, 2020, 29 (03) : 211 - 215
  • [8] Treatment of canine osteoarthritis with allogeneic platelet-rich plasma: review of five cases
    Catarino, Jose
    Carvalho, Pedro
    Santos, Sara
    Martins, Angela
    Requicha, Joao
    OPEN VETERINARY JOURNAL, 2020, 10 (02) : 226 - 231
  • [9] The effect of platelet-rich plasma injection in the treatment of androgenetic alopecia
    Bayat, Mousa
    Yazdanpanah, Mohammad Javad
    Alamdari, Daryoush Hamidi
    Banihashemi, Mahnaz
    Salehi, Maryam
    JOURNAL OF COSMETIC DERMATOLOGY, 2019, 18 (06) : 1624 - 1628
  • [10] PLATELET-RICH PLASMA AND SHOCKWAVE THERAPY COMBINATION FOR PEYRONIE'S DISEASE TREATMENT
    Epifanova, M.
    Kaprin, A.
    Kostin, A.
    Gvasalia, B.
    Chalyy, M.
    Artemenko, S.
    Epifanov, A.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S180 - S180